Kubota Pharmaceutical Holdings Co., Ltd. clinical trials
Also known as Acucela.
The registry lists 21 studies whose lead sponsor is Kubota Pharmaceutical Holdings Co., Ltd. or the company grouped under it. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 7, 2026.
Our grouping of 1 registry name, not the registry’s. See them and correct one ↓
- 21studies on the registry
- 2open to participants now
- 1reach primary completion within a year
Get an email when these change. Save the Kubota Pharmaceutical Holdings Co., Ltd. studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
What it is testing
The drugs Kubota Pharmaceutical Holdings Co., Ltd.’s studies test, most open studies first — 3 drugs with a page of their own. Each count opens the studies in search.
Open now Not open: under way, finished or stopped
Coming up
1 of Kubota Pharmaceutical Holdings Co., Ltd.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.
Phase 3 Other phases
- NNov ’26’26
- 1DDec
- JJan ’27’27
- FFeb
- MMar
- AApr
- MMay
- JJun
- JJul
- AAug
- SSep
- OOct
- NNov
The study
Add it to your calendar (.ics) → With an account.
All 21 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 08
- 09
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 420
- 21
- 22
- 23
- 24
- 25
- 126
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Kubota Pharmaceutical Holdings Co., Ltd.
- Kubota Vision Inc.21 studies →Subsidiary
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 21 of 21.
- A Controlled Evaluation of Optical Defocus Parameters on Transient Changes in Axial Length Using Kubota GlassNot yet recruitingNCT07686289Not applicable
Sponsor listed in the registry: Kubota Vision Inc.
- Electronic Spectacles Versus Low Dose Atropine in Young MyopesRecruitingNCT06034379Not applicable
Sponsor listed in the registry: Kubota Vision Inc.
- Kubota Glass Parameter Refinement StudyCompletedNCT06085430Not applicable
Sponsor listed in the registry: Kubota Vision Inc.
- Safety and Efficacy of Emixustat in Stargardt DiseaseCompletedNCT03772665Phase 3
Sponsor listed in the registry: Kubota Vision Inc.
- Binocular Peripheral Myopic Defocus Using a Clinical Prototype DeviceStatus unknownNCT05425108Not applicable
Sponsor listed in the registry: Kubota Vision Inc.
- Projected Peripheral Defocus Using a Wearable DeviceCompletedNCT04415684Not applicable
Sponsor listed in the registry: Kubota Vision Inc.
- Effects of Projected Peripheral Defocus on Ocular BiometricsCompletedNCT04388020Not applicable
Sponsor listed in the registry: Kubota Vision Inc.
- Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt DiseaseCompletedNCT03033108Phase 2
Sponsor listed in the registry: Kubota Vision Inc.
- Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic RetinopathyCompletedNCT02753400Phase 2
Sponsor listed in the registry: Kubota Vision Inc.
- Study Evaluating Retinal Health Monitoring System Thickness ModuleWithdrawnNCT04428242
Sponsor listed in the registry: Kubota Vision Inc.
- Study Evaluating Retinal Health Monitoring System Visual Acuity Module.CompletedNCT04169802
Sponsor listed in the registry: Kubota Vision Inc.
- Evaluation of the Retinal Health Monitoring System Thickness ModuleCompletedNCT04499703
Sponsor listed in the registry: Kubota Vision Inc.
- Safety and Efficacy Assessment Treatment Trials of Emixustat HydrochlorideCompletedNCT01802866Phase 2/3
Sponsor listed in the registry: Kubota Vision Inc.
- Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular DegenerationCompletedNCT02130531Phase 1
Sponsor listed in the registry: Kubota Vision Inc.
- Efficacy and Safety of Rebamipide in Subjects With Dry Eye SyndromeCompletedNCT01632137Phase 3
Sponsor listed in the registry: Kubota Vision Inc.
- Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic AtrophyCompletedNCT01002950Phase 2
Sponsor listed in the registry: Kubota Vision Inc.
- Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01410188Phase 1/2
Sponsor listed in the registry: Kubota Vision Inc.
- Safety and Tolerability of ACU-4429CompletedNCT00703183Phase 1
Sponsor listed in the registry: Kubota Vision Inc.
- Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry EyeCompletedNCT01027013Phase 2
Sponsor listed in the registry: Kubota Vision Inc.
- Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central CorneaCompletedNCT01057147Phase 2
Sponsor listed in the registry: Kubota Vision Inc.
- Safety and Tolerability of Repeat Doses of ACU-4429 in Healthy SubjectsCompletedNCT00942240Phase 1
Sponsor listed in the registry: Kubota Vision Inc.